ATRX is a predictive marker for endocrinotherapy and chemotherapy resistance in HER2-/HR+ breast cancer through the regulation of the AR, GLI3 and GATA2 transcriptional network
Article in Aging (December 2023)
The most recent citing publications are shown below. View all 7 publications that cite this research output on Dimensions.
Article in Aging (December 2023)
Article in The Journal of Clinical Endocrinology & Metabolism (November 2022)
Article in Frontiers in Oncology (November 2021)